Zheng Quan Zhi Xing·2025-07-07 16:07Group 1 - The legal opinion letter is issued by Beijing Wan Shang Tian Qin Law Firm regarding Beijing Chunli Zhengda Medical Device Co., Ltd for the 2025 first H-share general meeting of shareholders [2][3] - The meeting was convened by the company's board of directors, with the first meeting held on May 27, 2025, to propose the 2024 annual general meeting and the 2025 first A and H-share general meetings [2][3] - The H-share general meeting was postponed due to insufficient voting rights held by H-share shareholders, failing to meet the one-third requirement as per the company's articles of association [2][3] Group 2 - The H-share general meeting is scheduled to be held on July 7, 2025, at 10:00 AM in Tongzhou District, Beijing [3] - The qualifications of the attending shareholders were verified by Hong Kong Central Clearing and Settlement System, with 11,087,726 H-shares represented, accounting for 11.6541% of the total voting H-shares [3][4] - The meeting adopted a named voting method for the resolutions presented, and the resolution regarding granting the board of directors general authorization to repurchase H-shares was approved [4] Group 3 - The legal opinion concludes that the convening and holding procedures of the general meeting, the qualifications of attendees, the qualifications of the convener, and the voting procedures and results are all in compliance with relevant laws and regulations [4]